ReviewPoultry science2026
The role of cyclooxygenase-2 in oxidative stress and inflammation: Implications for poultry health and production.
Review in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Oxidative stress and inflammation commonly occur in modern poultry farming, where they are closely linked mechanistically during the progression of disease and adaptation to stressors. This review synthesizes current evidence to outline cyclooxygenase-2 (COX-2) and downstream prostaglandin E2 (PGE₂) signaling via EP receptors as a key molecular nexus that connects excessive reactive oxygen species (ROS) with sustained inflammatory damage. In poultry, a range of stressors, such as heat stress, high stocking density, mycotoxin exposure, heavy metals, and pathogen challenges, promote ROS accumulation from sources such as mitochondria and NADPH oxidase (NOX). These disruptions in redox balance trigger regulatory pathways involving MAPK and NF-κB/AP-1, thereby upregulating PTGS2 (the gene for COX-2) and microsomal prostaglandin E synthase-1 (mPGES-1), leading to increased PGE₂ production. In turn, the PGE₂/EP signaling pathway can enhance NOX activity, alter both innate and adaptive immune functions, and exacerbate barrier dysfunction in the intestine, liver, respiratory mucosa, and immune-related organs, establishing a reinforcing loop of ROS, COX-2, and PGE₂. We further discuss how the effects of COX-2 vary by tissue and pathogen, contributing to slowed growth, disrupted immunity, enhanced viral susceptibility, and damage to organs, and discuss potential intervention approaches such as Nrf2-focused antioxidants, nutrients that strengthen barriers, and targeted modulation of COX-2 and mPGES-1 activity and EP receptor signaling to disrupt the link between oxidative load and escalating inflammation. Finally, we outline a framework integrating standardized stress and pathogen challenges with eicosanoid and EP receptor profiling to guide targeted interventions on the COX-2 prostaglandin network in poultry.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.